CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - BIT:1CVS - US1266501006 - Common Stock
70 EUR
+1.63 (+2.38%)
1CVS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
1CVS had positive earnings in the past year.
1CVS had a positive operating cash flow in the past year.
1CVS had positive earnings in each of the past 5 years.
In the past 5 years 1CVS always reported a positive cash flow from operatings.
1.2 Ratios
1CVS has a worse Return On Assets (1.75%) than 64.52% of its industry peers.
With a Return On Equity value of 5.86%, 1CVS perfoms like the industry average, outperforming 41.94% of the companies in the same industry.
1CVS has a Return On Invested Capital (4.57%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for 1CVS is in line with the industry average of 6.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | 5.86% | ||
| ROIC | 4.57% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
Looking at the Profit Margin, with a value of 1.17%, 1CVS is doing worse than 61.29% of the companies in the same industry.
In the last couple of years the Profit Margin of 1CVS has declined.
Looking at the Operating Margin, with a value of 2.65%, 1CVS is doing worse than 70.97% of the companies in the same industry.
In the last couple of years the Operating Margin of 1CVS has declined.
1CVS's Gross Margin of 13.82% is on the low side compared to the rest of the industry. 1CVS is outperformed by 61.29% of its industry peers.
1CVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.65% | ||
| PM (TTM) | 1.17% | ||
| GM | 13.82% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CVS is destroying value.
1CVS has less shares outstanding than it did 1 year ago.
1CVS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CVS has a worse debt to assets ratio.
2.2 Solvency
1CVS has an Altman-Z score of 2.23. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.23, 1CVS is in line with its industry, outperforming 58.06% of the companies in the same industry.
The Debt to FCF ratio of 1CVS is 13.91, which is on the high side as it means it would take 1CVS, 13.91 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.91, 1CVS is doing worse than 61.29% of the companies in the same industry.
1CVS has a Debt/Equity ratio of 0.78. This is a neutral value indicating 1CVS is somewhat dependend on debt financing.
1CVS has a Debt to Equity ratio (0.78) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 13.91 | ||
| Altman-Z | 2.23 |
ROIC/WACC0.6
WACC7.6%
2.3 Liquidity
A Current Ratio of 0.80 indicates that 1CVS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.80, 1CVS is doing worse than 67.74% of the companies in the same industry.
1CVS has a Quick Ratio of 0.80. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, 1CVS is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
1CVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.13%.
The Earnings Per Share has been decreasing by -5.20% on average over the past years.
The Revenue has been growing slightly by 6.44% in the past year.
Measured over the past years, 1CVS shows a small growth in Revenue. The Revenue has been growing by 7.74% on average per year.
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%
3.2 Future
The Earnings Per Share is expected to grow by 10.91% on average over the next years. This is quite good.
Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 4.71% on average per year.
EPS Next Y18.7%
EPS Next 2Y15.58%
EPS Next 3Y14.55%
EPS Next 5Y10.91%
Revenue Next Year6.16%
Revenue Next 2Y5%
Revenue Next 3Y5.09%
Revenue Next 5Y4.71%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.82 indicates a correct valuation of 1CVS.
Compared to the rest of the industry, the Price/Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 80.65% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.83, 1CVS is valued rather cheaply.
The Price/Forward Earnings ratio is 11.23, which indicates a very decent valuation of 1CVS.
1CVS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1CVS is cheaper than 74.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, 1CVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.82 | ||
| Fwd PE | 11.23 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CVS indicates a slightly more expensive valuation: 1CVS is more expensive than 64.52% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.57 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CVS's earnings are expected to grow with 14.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y15.58%
EPS Next 3Y14.55%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.28%, 1CVS has a reasonable but not impressive dividend return.
1CVS's Dividend Yield is rather good when compared to the industry average which is at 2.55. 1CVS pays more dividend than 90.32% of the companies in the same industry.
1CVS's Dividend Yield is a higher than the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
5.2 History
The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
74.62% of the earnings are spent on dividend by 1CVS. This is not a sustainable payout ratio.
The dividend of 1CVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP74.62%
EPS Next 2Y15.58%
EPS Next 3Y14.55%
BIT:1CVS (10/15/2025, 7:00:00 PM)
70
+1.63 (+2.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.11%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap88.78B
Revenue(TTM)386.64B
Net Income(TTM)4.53B
Analysts80
Price Target69.65 (-0.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
Yearly Dividend2.28
Dividend Growth(5Y)5.72%
DP74.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.87%
Min EPS beat(2)22.99%
Max EPS beat(2)30.76%
EPS beat(4)3
Avg EPS beat(4)13.15%
Min EPS beat(4)-28.4%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)5.23%
EPS beat(12)10
Avg EPS beat(12)4.69%
EPS beat(16)14
Avg EPS beat(16)4.93%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)9
Avg Revenue beat(12)2.1%
Revenue beat(16)13
Avg Revenue beat(16)2.16%
PT rev (1m)-0.44%
PT rev (3m)0.26%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-5.25%
EPS NY rev (1m)0.09%
EPS NY rev (3m)3.84%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.82 | ||
| Fwd PE | 11.23 | ||
| P/S | 0.27 | ||
| P/FCF | 21.57 | ||
| P/OCF | 13.62 | ||
| P/B | 1.33 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.46
EY7.8%
EPS(NY)6.24
Fwd EY8.91%
FCF(TTM)3.25
FCFY4.64%
OCF(TTM)5.14
OCFY7.34%
SpS262.52
BVpS52.54
TBVpS-27.19
PEG (NY)0.69
PEG (5Y)N/A
Graham Number80.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | 5.86% | ||
| ROCE | 6.23% | ||
| ROIC | 4.57% | ||
| ROICexc | 5% | ||
| ROICexgc | 21.47% | ||
| OM | 2.65% | ||
| PM (TTM) | 1.17% | ||
| GM | 13.82% | ||
| FCFM | 1.24% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 13.91 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.72% | ||
| Interest Coverage | -3.41 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.5% | ||
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 2.23 |
F-Score5
WACC7.6%
ROIC/WACC0.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
EPS Next Y18.7%
EPS Next 2Y15.58%
EPS Next 3Y14.55%
EPS Next 5Y10.91%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%
Revenue Next Year6.16%
Revenue Next 2Y5%
Revenue Next 3Y5.09%
Revenue Next 5Y4.71%
EBIT growth 1Y-20.52%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year40.75%
EBIT Next 3Y19.75%
EBIT Next 5Y18.23%
FCF growth 1Y-72.95%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-63.11%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%
CVS HEALTH CORP / 1CVS.MI FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1CVS.MI.
Can you provide the valuation status for CVS HEALTH CORP?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
What is the profitability of 1CVS stock?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for 1CVS stock?
The Price/Earnings (PE) ratio for CVS HEALTH CORP (1CVS.MI) is 12.82 and the Price/Book (PB) ratio is 1.33.
Can you provide the expected EPS growth for 1CVS stock?
The Earnings per Share (EPS) of CVS HEALTH CORP (1CVS.MI) is expected to grow by 18.7% in the next year.